FDC Global View: January 2013, Issue No. 172
Abstract: Best Quality Practices for Biomedical Research in Drug Development, 23rd Annual ASQ-FDC West Coast Conference– A Success, New Slate of Officers, Drug Administration Law of the People’s Republic of China (Part II), Séralini et al. Study Conclusions Not Supported by Data Says EU Risk Assessment Community, FDA Approves First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology.
Keywords: China
Already a member? Access this Content
You will need Adobe Reader to view this PDF document.
Download the free Reader from Adobe
You must log in to comment. Please log in or register. Comments FAQ



